Aim and Purpose of the Swiss PostASCO Event
The annual meeting of the American Society of Clinical Oncology (ASCO) is a leading event in the field of oncology with a strong focus on research and innovation. As not all Swiss experts in medical oncology are able to attend the ASCO annual meeting, the PostASCO Academy is organizing each year a Swiss PostASCO event in Switzerland after the official annual meeting under the patronage of the Swiss Group for Clinical Cancer Research SAKK. The event aims to convey scientific news to all oncological specialists in a simple way.

Chair and co-chair
Chair and co-chair of the Swiss PostASCO event usually are the president and the vice-president of the SAKK.

Scientific content
The scientific content of the event is the sole responsibility of the chair, the co-chair and the invited speakers.

Speakers and themes
Switzerland wide recognized speakers present the scientific results of the ASCO Annual meeting to an audience of specialist and experts. Relevant innovations and indications are being covered with the choice of topics.

The Swiss Group for Clinical Cancer Research SAKK is responsible for the organization. The four main sponsors Novartis Pharma Schweiz AG, Janssen Cilag AG, Merck (Schweiz) AG und Sanofi-Aventis (Suisse) SA support the SAKK in the organization. However, they have no influence on the content of the program or the choice of speakers.

The program and the lectures of the Swiss PostASCO event are being displayed on the website Owner of the website is the SAKK. Being the operator of the website, SAKK is exclusively responsible for the hosting and the content of the website.

Conflict of interest
All participating medical professionals obligate themselves to disclose any conflict of interest.

Adherence of the guidelines for professional education
The Swiss PostASCO event adheres to the guidelines for professional education of SGMO as stated under The SAKK applies for SGMO credits which are being allocated for the attendance of the event.